Identification of CD36 as a contributor in inflammatory response of rheumatoid arthritis and screening of feasible bioactive drugs targeting it
CD36 is a potential biomarker and therapeutic target associated with synovial inflammation of RA, and piceatannol and epicatechin are potential natural drugs for RA treatment. Overall, these findings provide new insights into the clinical diagnosis and treatment of RA.
Authors
- Xiaowan Wang (ORCID: https://orcid.org/0000-0001-9152-8908)
- Dan Xuan
- Lı Wang (ORCID: https://orcid.org/0000-0003-1688-064X)
- Dandan Feng
- Yonghui Xia
Institutions
- Wannan Medical College (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1186/s41065-025-00450-3
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.32